Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis

Rationale & Objective: In FIDELITY, finerenone improved cardiorenal outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes. This analysis explores the efficacy and safety of finerenone in Hispanic patients. Study Design: Post hoc analysis of the FIDELITY prespecified pooled a...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Sylvia E. Rosas, Luis M. Ruilope, Stefan D. Anker, Bertram Pitt, Peter Rossing, Andres Angelo Cadena Bonfanti, Ricardo Correa-Rotter, Fernando González, Carlos Francisco Jaramillo Munoz, Pablo Pergola, Guillermo E. Umpierrez, Andrea Scalise, Charlie Scott, Robert Lawatscheck, Amer Joseph, George L. Bakris
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2023-10-01
Serie:	Kidney Medicine
Soggetti:	Type 2 diabetes chronic kidney disease cardiorenal Hispanic patients finerenone nonsteroidal mineralocorticoid receptor antagonist
Accesso online:	http://www.sciencedirect.com/science/article/pii/S259005952300122X
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!